Link to full article Patients with Parkinson’s disease are being given life-changing smart watches that allow doctors to remotely assess their condition in a pioneering project to revolutionise NHS care. The cutting-edge gadget containing sensors, known as a Parkinson’s Kinetigraph (PKG), is worn around the clock for six days to monitor patients’ movements at home. […]
Link to Full Article Overall, the device provided information for better treatment plans, allowed doctors to assess the efficacy of treatments, and improved doctor-patient communication. The findings were reported in “PKG Movement Recording System Use Shows Promise in Routine Clinical Care of Patients With Parkinson’s Disease,” a study published in the journal Frontiers in Neurology. The […]
Link to Full Article Unlike patient-reported motor diaries, PKG distinguishes among different groups of fluctuators and identifies high levels of dyskinesia among patients who deny having dyskinesia symptoms PORTSMOUTH, NH USA, LONDON, UK and MELBOURNE, Australia, July 23, 2019 – Global Kinetics Corporation Ltd. today announced the publication of a study demonstrating that the use […]
Link to Full Article Executive Summary A new study shows the Personal KinetiGraph wearable monitor can help clinicians identify the Parkinson’s disease patients most likely to benet from device-assisted therapies, including deep brain stimulation. Global Kinetics’ Personal KinetiGraph (PKG) wearable sensor system can identify the best candidates for deviceassisted therapies for Parkinson’s disease, including deep […]
Link to Full Article A new study shows the Personal KinetiGraph wearable monitor can help clinicians identify the Parkinson’s disease patients most likely to benet from device-assisted therapies, including deep brain stimulation. Global Kinetics’ Personal KinetiGraph (PKG) wearable sensor system can identify the best candidates for deviceassisted therapies for Parkinson’s disease, including deep brain stimulation, […]
Link to Full Article Novel screening tool provides first objective assessment for managing referral for deviceassisted therapy (DAT), including deep brain stimulation (DBS) and infusion therapies, and has potential to improve management of Parkinson’s Disease PORTSMOUTH, N.H. and LONDON and MELBOURNE, Australia, June 04, 2019 (GLOBE NEWSWIRE) — Global Kinetics Corporation Ltd. today announced the […]
Link to Full Article Data Recently Presented at the 2019 American Academy of Neurology’s Annual Meeting APPRISE Clinical Study Continues Enrollment at 10 Movement Disorder Clinics in the U.S. PORTSMOUTH, N.H. and LONDON and MELBOURNE, Australia, May 07, 2019 (GLOBE NEWSWIRE) — Global Kinetics today reported data that was recently presented at poster presentation sessions […]
Link to full article A pilot project in the United Kingdom is testing a wrist device that is worn like a watch, called Personal Kinetigraph (PKG), to help Parkinson’s patients and their specialist healthcare providers to monitor their condition at home. The PKG, developed by Global Kinetics, will be tested in the “Developing Home-based Parkinson’s Care” project, […]
Link to full article PORTSMOUTH, NH USA, and MELBOURNE, Australia, April 2, 2019 Global Kinetics Pty Ltd., a medical device company focused on the development and commercialization of the first FDA-cleared and CE-marked wearable watch for the objective treatment and management of Parkinson’s disease, called the Personal KinetiGraph® (PKG®), today announced the appointment of Gregory […]
– Additional monitoring data helped clinicians optimize drug therapy in nearly onethird of study patients – PORTSMOUTH, NH USA, LONDON, UK, MELBOURNE, Australia, and MOUNTAIN VIEW, CA USA February 4, 2019 – Global Kinetics Corporation Ltd., in conjunction with the Parkinson’s Institute and Clinical Center, today announced the publication of a joint study in the […]